133 | LONG‐TERM SURVIVAL TRENDS IN ADVANCED‐STAGE MANTLE CELL LYMPHOMA: A POOLED ANALYSIS OF SIX RANDOMIZED PHASE III TRIALS FROM 1996 TO 2020

Documenti analoghi

• 303 | FERTILE: A LONG‐TERM ANALYSIS OF FERTILITY AMONG WOMEN TREATED WITH R‐ACVBP/R‐CHOP FOR DIFFUSE LARGE B‐CELL LYMPHOMA, A RETROSPECTIVE, POOLED STUDY OF LYSA TRIALS
  di: L. Oberic, et al.
  Pubblicazione: (2025)
• 46 | EFFICACY OF RITUXIMAB‐BENDAMUSTINE WITH OR WITHOUT ACALABRUTINIB IN PATIENTS WITH UNTREATED, HIGH‐RISK MANTLE CELL LYMPHOMA: AN ANALYSIS OF THE PHASE 3 ECHO TRIAL
  di: M. Dreyling, et al.
  Pubblicazione: (2025)
• 267 | EVALUATION OF ESTABLISHED PROGNOSTIC MARKERS IN YOUNGER MANTLE CELL LYMPHOMA PATIENTS UNDER IBRUTINIB CONTAINING REGIMENS—AN ANALYSIS EMBEDDED IN THE MULTIPLY PROJECT
  di: K. Gutmair, et al.
  Pubblicazione: (2025)
• 275 | RADIOTHERAPY IN PATIENTS WITH ADVANCED STAGE MANTLE CELL LYMPHOMA ACHIEVES DURABLE LOCAL TUMOR CONTROL—A SAKK/GLA/EMCL REAL‐WORLD‐ANALYSIS FROM THE EMCL‐REGISTRY
  di: L. Simon, et al.
  Pubblicazione: (2025)
• 614 | LONG TERM FOLLOW‐UP OF PATIENTS WITH MANTLE CELL LYMPHOMA, WHO UNDERWENT HIGH‐DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN FIRST REMISSION
  di: J. Romejko‐Jarosinska, et al.
  Pubblicazione: (2025)